Ainos, Inc. (AIMDW)
| Market Cap | 9.79M +16.5% |
| Revenue (ttm) | 18,111 -82.9% |
| Net Income | -13.94M |
| EPS | -2.80 |
| Shares Out | 7.36M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1 |
| Open | 0.0855 |
| Previous Close | n/a |
| Day's Range | 0.0855 - 0.0855 |
| 52-Week Range | 0.0502 - 0.9490 |
| Beta | 2.45 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 12, 2026 |
About AIMDW
Ainos, Inc., a dual-platform company, focusing artificial intelligence–based smelltech technologies and immune therapeutics. It offers AI Nose, an AI-based electronic olfaction system, which uses a smell language model to digitize scent into Smell IDs and turning into machine-readable data. The company provides its platforms for semiconductor manufacturing, robotics, and smart manufacturing industries; as well as senior care and women’s health sectors. In addition, it develops VELDONA, a low-dose oral interferon platform for human and animal he... [Read more]
News
Ainos Expands Smell AI With Growing Real-World Scent Dataset for Physical AI
AI Nose deployments have generated approximately 613 million industrial scent data points since December 2025, advancing Ainos' vision of a smell intelligence network HOUSTON, TX / ACCESS Newswire / J...
VASRO Research Highlights Ainos' Expansion of Smell AI Into Patient-Level Breath Intelligence
HOUSTON, TX / ACCESS Newswire / June 22, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a Smell AI company digitizing scent into machine-readable data for artificial intell...
Ainos Expands Smell AI Platform into Digital Breath Intelligence Through National Taiwan University Research Program
Program expands Ainos' Smell AI platform from environmental intelligence into digital breath intelligence for emergency medicine research HOUSTON, TX / ACCESS Newswire / June 17, 2026 / Ainos, Inc. (N...
Ainos Transcript: RedChip Future Tech Investor Conference
A new AI data layer is being created by digitizing scent, enabling machines to interpret chemical signals. Early deployments in semiconductor manufacturing and healthcare are building a proprietary data moat, with strategic partnerships accelerating adoption and ecosystem growth.
Ainos Releases 2026 Mid-Year CEO Letter to Shareholders
Building the Olfactory Layer of Physical AI Highlighting Progress Across Semiconductor Manufacturing, Healthcare Infrastructure and Physical AI Applications HOUSTON, TX / ACCESS Newswire / June 8, 202...
VASRO Research Highlights Ainos Smell AI Expansion into Emergency Department Operations
HOUSTON, TX / ACCESS Newswire / June 5, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a Smell AI company digitizing scent into machine-readable data for artificial intelli...
Zacks SCR Discusses Ainos' Expansion of Smell AI into Healthcare Infrastructure Through NTUH Study
HOUSTON, TX / ACCESS Newswire / June 3, 2026 / Ainos, Inc. (NASDAQ:AIMD, AIMDW) ("Ainos" or the "Company"), a Smell AI company digitizing scent into machine-readable data for artificial intelligence a...
Ainos Launches Smell AI Study at National Taiwan University Hospital for ER Overcrowding and Respiratory Infection Risk Analysis
AI Nose Expands from Semiconductor Facilities into Frontline Healthcare Infrastructure HOUSTON, TX / ACCESS Newswire / June 1, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company")...
VASRO Research Highlights Ainos AI Nose Commercialization Progress and Semiconductor Industry Shift Toward AI-Driven Environmental Intelligence
HOUSTON, TX / ACCESS Newswire / May 20, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company") today highlighted a new research update published by VASRO GmbH discussing AI Nose, th...
Ainos Reports First Quarter 2026 Financial Results and Highlights Smell AI Execution Across Semiconductors and Healthcare Infrastructure Markets
HOUSTON, TX / ACCESS Newswire / May 13, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company") today announced financial results for the first quarter ended March 31, 2026 and provi...
Ainos Earnings release: Q1 2026
Ainos released its Q1 2026 earnings on May 13, 2026, summarizing the period's financial results.
Ainos Quarterly report: Q1 2026
Ainos has published its Q1 2026 quarterly earnings report on May 13, 2026.
Ainos Updates Standard Industrial Classification Code to Reflect Smell AI Business Focus
Updated classification reflects Ainos' transition toward AI-powered scent intelligence commercialization HOUSTON, TX / ACCESS Newswire / May 11, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos"...
VASRO: Ainos Expands Smell AI from Industrials into Healthcare Infrastructure, Reinforcing AI Infrastructure Positioning and Multi-Vertical Scalability
2026 Identified as a Key Scale-Up Phase with Expanding Market Verticals and Accelerating Data Flywheel HOUSTON, TX / ACCESS Newswire / April 17, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) today hi...
Ainos, MacKay Memorial Hospital and Topco Scientific Partner to Advance Smell AI Deployment in High-Risk Hospital Environments
Expands AI Nose platform from industrial safety into clinical infrastructure HOUSTON, TX / ACCESS Newswire / April 8, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) today announced a partnership with ...
Ainos Slides: Investor presentation
Ainos has posted slides in relation to its latest quarterly earnings report, which was published on April 6, 2026.
VASRO Research Highlights Ainos' Smell AI Commercial Progress and 2026 Deployment Momentum
Report highlights transition to deployment-driven growth, with visible semiconductor rollout and early customer-backed revenue Smell AI, powered by AI Nose, is emerging as a new AI perception layer, s...
Ainos Reports Full Year 2025 Financial Results and Highlights Commercial Momentum Entering 2026
AI Nose drove 499% revenue growth in 2025, with gross margin turning positive to 82.9% 2025 partnerships now driving scaled AI Nose deployments in 2026, supported by disciplined financing HOUSTON, TX ...
Ainos Earnings release: Q4 2025
Ainos released its Q4 2025 earnings on March 30, 2026, summarizing the period's financial results.
Ainos Annual report: Q4 2025
Ainos has published its Q4 2025 annual report on March 30, 2026.
The Wall Street Journal Highlights Emerging "Smell AI" - Ainos Advances Commercial Deployment in Semiconductor Environments
As AI expands beyond vision and language, Ainos advances commercial deployment of AI Nose in industrial environments-positioning the Company at the forefront of this emerging category HOUSTON, TX / AC...
Water Tower Research Highlights Ainos' Scaling Momentum Across Semiconductor Value Chain
AI Nose deployment into front-end wafer fabrication facilities marks a critical validation step in semiconductor manufacturing environments Recurring revenue visibility strengthens as AI Nose deployme...
Ainos Expands AI Nose Validation in Front-End Wafer Fabs with 200 Targeted Deployments in Q1 2026
Company affirms execution milestones, subscription activation roadmap, and long-term infrastructure vision remain unchanged despite market volatility HOUSTON, TEXAS / ACCESS Newswire / March 9, 2026 /...
Ainos Issues Shareholder Letter on Phased AI Nose Deployment of Up to 20,000 Systems and Scalable Recurring Revenue Opportunity
HOUSTON, TEXAS / ACCESS Newswire / March 2, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company") today issued the following letter from Chairman, President and Chief Executive Off...
Ainos Activates Industrial-Scale Deployment Roadmap of Up to 20,000 Units, Advancing AI Infrastructure Integration in Semiconductor Production Environments
HOUSTON, TEXAS / ACCESS Newswire / February 23, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company") today announced the activation of a phased industrial deployment roadmap under...